Home › Funds › Baader Bank Aktiengesellschaft › EW

Baader Bank Aktiengesellschaft position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Baader Bank Aktiengesellschaft reported holding 66,430 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$6.0M, representing 0.70% of its reported portfolio and ranking #38 among its reported holdings. Baader Bank Aktiengesellschaft has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)66.43K sh
Reported value held$6.01M
Portfolio Weight0.70%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Baader Bank Aktiengesellschaft's EW position evolved

Baader Bank Aktiengesellschaft first disclosed a stake in EW in Q3 2023 at 141,096 shares (US$9.8M). The position peaked in Q4 2023 at 160,551 shares, worth US$12.2M. Across 12 filings, Baader Bank Aktiengesellschaft increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 66,430 shares valued at US$6.0M — an increase of 43,330 shares quarter over quarter.. Notable position changes include a 73% trim in Q4 2025 (shares fell 6% over the following quarter), a 204% increase in Q1 2026 (shares rose 13% over the following quarter), a 188% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 141.10K $9.77M New
Q4 2023 160.55K $12.24M Add
Q1 2024 60.20K $5.75M Reduce
Q2 2024 95.00K $8.78M Add
Q3 2024 95.00K $6.27M Hold
Q4 2024 95.00K $7.03M Hold
Q1 2025 76.00K $5.51M Reduce
Q2 2025 38.00K $2.97M Reduce
Q3 2025 27.70K $2.15M Reduce
Q4 2025 7.60K $647.90K Reduce
Q1 2026 23.10K $1.85M Add
Q2 2026 66.43K $6.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Baader Bank Aktiengesellschaft held EW?

Baader Bank Aktiengesellschaft has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Baader Bank Aktiengesellschaft's current position in EW?

As of Q2 2026, Baader Bank Aktiengesellschaft holds 66.43K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $6.01M, representing 0.70% of its reported portfolio and ranking #38.

Has Baader Bank Aktiengesellschaft been buying or selling EW?

In the latest 13F filing (Q2 2026), Baader Bank Aktiengesellschaft increased its position in EW. The position peaked in Q4 2023 at 160.55K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.